The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Regeneron Announces Upcoming 2013 Investor Conference Presentations

Wednesday, May 08, 2013

Regeneron Announces Upcoming 2013 Investor Conference Presentations

09:30 EDT Wednesday, May 08, 2013

TARRYTOWN, N.Y., May 8, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

  • UBS Global Healthcare Conference on Monday, May 20, 2013.  The presentation is scheduled for 10:00 a.m. Eastern Time.
  • 38th Annual dbAccess Healthcare Conference on Wednesday, May 29, 2013.  The presentation is scheduled for 8:40 a.m. Eastern Time.
  • Jefferies 2013 Healthcare Conference on June 3, 2013.  The presentation is scheduled for 9:00 a.m. Eastern Time.
  • Goldman Sachs 34th Annual Global Healthcare Conference on Tuesday, June 11, 2013.  The presentation is scheduled for 11:40 a.m. Eastern Time (8:40 a.m. Pacific Time).

The presentations may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  An archived version of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.

Contact Information:

Manisha Narasimhan, Ph.D.    

Peter Dworkin

Investor Relations             

Corporate Communications                           

914.847.5126             

914.847.7640             

manisha.narasimhan@regeneron.com  

peter.dworkin@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections